Full Text View
Tabular View
No Study Results Posted
Related Studies
Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) Pathology (FD)
This study is enrolling participants by invitation only.
Study NCT00687752   Information provided by Hippocration General Hospital
First Received: May 28, 2008   Last Updated: May 30, 2008   History of Changes

May 28, 2008
May 30, 2008
May 2007
April 2008   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00687752 on ClinicalTrials.gov Archive Site
 
 
 
Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of Central Nervous System (CNS) Pathology
Sonographic Assessment of Fetal Deglutition Associated With Hydramnion:Its Absence is Indicative of CNS Pathology? a Report on Two Cases.

310 singleton pregnancies (22-35 weeks) enrolled into the study. We assessed sonographically the fetal larynx in an axial plane through the mandible and observed the fetal deglutition movements .

310 singleton pregnancies (22-35 weeks) enrolled into the study. We assessed sonographically the fetal larynx in an axial plane through the mandible and observed the fetal deglutition movements .We encountered two cases of hydramnios were no deglutition movements could be noted. In all other cases the deglutition was normal. The motivation to conduct the current observational prospective study was to assess whether there is a link between absence of fetal deglutition and CNS pathology of the fetus. In the first case the fetus deceased at 35 weeks of gestation; obduction was declined by the parents. In the second case caesarian section at 33 weeks was carried out recently due to fetal distress. The infant is still in uncapable of swallowing and there for is under investigation at the neonatal center of our hospital.

 
Observational
Case Control, Prospective
Hydramnios
 
  • hydramnios
  • normal
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Enrolling by invitation
310
May 2009
April 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • singleton pregnancy(22-35 weeks)

Exclusion Criteria:

  • positive toxoplasmosis screening,drug and/or antidepressants addiction.
Female
 
Yes
Contact information is only displayed when the study is recruiting subjects
Greece
 
NCT00687752
assist. professor THEOHARIS TANTANASIS, 2nd department OB/GYN Hippocration General Hospital
27052008
Hippocration General Hospital
 
Principal Investigator: THEOHARIS A TANTANASIS, ASSIST PROF 2nd dept OB/GYN ARISTOTLE UNIV. THESSALONIKI GREECE
Study Chair: JOHN M TZAFETTAS, PROF 2nd dept OBGYN ARISTOTLE UNIV. THESSALONIKI GREECE
Hippocration General Hospital
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP